⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for malignant solid tumor

Every month we try and update this database with for malignant solid tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid TumorsNCT06057038
Malignant Solid...
GEN1042
Pembrolizumab
Cisplatin
Carboplatin
5-Fluorouracil
18 Years - Genmab
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related PainNCT01846429
Tumor
Cancer
Pain
Malignant Solid...
Unresectable Ma...
Hematologic Mal...
Multiple Myelom...
Lymphoma
Neoplasm Metast...
Sodium Bicarbon...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
A Study Using Olaparib Tablets for Subjects With Advanced Solid Tumours.NCT03553108
Malignant Solid...
Olaparib Treatm...
Olaparib Treatm...
Olaparib Treatm...
Olaparib Treatm...
18 Years - 130 YearsAstraZeneca
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerNCT00452413
Non-Small Cell ...
Malignant Solid...
enzastaurin
erlotinib
18 Years - Eli Lilly and Company
Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceNCT03694249
Malignant Solid...
Ifetroban Sodiu...
Placebo
18 Years - Vanderbilt-Ingram Cancer Center
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid TumorsNCT05141474
Epithelial Tumo...
Malignant Solid...
NEXTGEN-TIL
Non-myeloablati...
Interleukin-2
18 Years - Vall d'Hebron Institute of Oncology
GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid TumorsNCT04083599
Malignant Solid...
Non Small Cell ...
Colorectal Canc...
Melanoma
Head and Neck S...
Pancreatic Duct...
GEN1042
Pembrolizumab
Cisplatin
Carboplatin
5-FU
Gemcitabine
Nab paclitaxel
Pemetrexed
Paclitaxel
18 Years - Genmab
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid TumorsNCT06057038
Malignant Solid...
GEN1042
Pembrolizumab
Cisplatin
Carboplatin
5-Fluorouracil
18 Years - Genmab
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)NCT04151342
Cancer
Malignancies Mu...
Malignant Solid...
Cancer, Therapy...
Molecular Seque...
Genetic Alterat...
Gene Fusion
Receptor Tyrosi...
RTK Family Gene...
Ras (Kras or Nr...
Cancer treatmen...
Patient-reporte...
18 Years - University Health Network, Toronto
A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has SpreadNCT01648764
Malignant Solid...
Solid Tumor
Metastatic Tumo...
LY2334737
18 Years - Eli Lilly and Company
A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001NCT02096341
Malignant Solid...
Lymphomas
RRx-001
18 Years - EpicentRx, Inc.
Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceNCT03694249
Malignant Solid...
Ifetroban Sodiu...
Placebo
18 Years - Vanderbilt-Ingram Cancer Center
A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients MalignanciesNCT03834662
Malignant Solid...
AVID200
18 Years - Formation Biologics
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung CancerNCT00452413
Non-Small Cell ...
Malignant Solid...
enzastaurin
erlotinib
18 Years - Eli Lilly and Company
A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid TumorsNCT06057038
Malignant Solid...
GEN1042
Pembrolizumab
Cisplatin
Carboplatin
5-Fluorouracil
18 Years - Genmab
A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid TumorsNCT03192345
Malignant Solid...
SAR439459
Cemiplimab REGN...
18 Years - Sanofi
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid TumorsNCT01670175
Malignant Solid...
Childhood Solid...
Sirolimus, Cycl...
- 25 YearsUniversity of California, San Francisco
Pragmatic Research of Acupuncture and Counseling eXtended to Inpatient ServicesNCT03905720
Malignant Solid...
Pain
Acupuncture
Pain Counseling
21 Years - University of California, San Francisco
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant TumorsNCT04145622
Advanced Solid ...
Malignant Solid...
Ifinatamab deru...
18 Years - Daiichi Sankyo
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related PainNCT01846429
Tumor
Cancer
Pain
Malignant Solid...
Unresectable Ma...
Hematologic Mal...
Multiple Myelom...
Lymphoma
Neoplasm Metast...
Sodium Bicarbon...
18 Years - H. Lee Moffitt Cancer Center and Research Institute
GEN1042 Safety Trial and Anti-tumor Activity in Subjects With Malignant Solid TumorsNCT04083599
Malignant Solid...
Non Small Cell ...
Colorectal Canc...
Melanoma
Head and Neck S...
Pancreatic Duct...
GEN1042
Pembrolizumab
Cisplatin
Carboplatin
5-FU
Gemcitabine
Nab paclitaxel
Pemetrexed
Paclitaxel
18 Years - Genmab
Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination TherapyNCT06391775
Malignant Solid...
GEN1055
Pembrolizumab
Standard Chemot...
18 Years - Genmab
A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has SpreadNCT01648764
Malignant Solid...
Solid Tumor
Metastatic Tumo...
LY2334737
18 Years - Eli Lilly and Company
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant TumorsNCT04145622
Advanced Solid ...
Malignant Solid...
Ifinatamab deru...
18 Years - Daiichi Sankyo
A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid TumorsNCT04571892
Malignant Solid...
Super circulati...
18 Years - 75 YearsShanghai East Hospital
Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsNCT01639911
Malignant Neopl...
CNS Malignancy
Malignant Neopl...
Genitourinary N...
Head and Neck N...
Melanoma
Malignant Neopl...
Alisertib
Pazopanib
18 Years - University of Illinois at Chicago
Targeted T-cell Therapy in Solid TumorsNCT04076137
Malignant Solid...
Targeted T-cell...
18 Years - 75 YearsBenhealth Biopharmaceutical (Shenzhen) Co., Ltd.
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid TumorsNCT05727839
Cutaneous Tumor
Malignant Solid...
JCXH-211 Inject...
18 Years - 75 YearsImmorna Biotherapeutics, Inc.
A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid TumorsNCT04632108
Malignant Solid...
ASKB589 Injecti...
18 Years - 75 YearsJiangsu Aosaikang Pharmaceutical Co., Ltd.
Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid TumorNCT03551795
Malignant Solid...
Infusion of iNK...
18 Years - 65 YearsShanghai Public Health Clinical Center
An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With NivolumabNCT02754141
Malignant Solid...
BMS-986179
Nivolumab
rHuPH20
18 Years - Bristol-Myers Squibb
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)NCT05103358
Tumor
Tumor, Solid
Metastasis
Metastatic Canc...
Cancer
Cancer Metastat...
Tumors
Neoplasms
Neoplasm Metast...
Solid Tumor
Advanced Solid ...
Advanced Cancer
Malignant Solid...
Malignant Solid...
Malignant Neopl...
Malignant Tumor
TSC
TSC1
TSC2
Metastatic Soli...
Metastatic Neop...
nab-sirolimus
12 Years - Aadi Bioscience, Inc.
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid TumorsNCT05727839
Cutaneous Tumor
Malignant Solid...
JCXH-211 Inject...
18 Years - 75 YearsImmorna Biotherapeutics, Inc.
ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in JapanNCT00836888
Malignant Solid...
ONO-4538
20 Years - Ono Pharmaceutical Co. Ltd
Hydroxychloroquine + Vorinostat in Advanced Solid TumorsNCT01023737
Malignant Solid...
Hydroxychloroqu...
Vorinostat
16 Years - The University of Texas Health Science Center at San Antonio
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)NCT05103358
Tumor
Tumor, Solid
Metastasis
Metastatic Canc...
Cancer
Cancer Metastat...
Tumors
Neoplasms
Neoplasm Metast...
Solid Tumor
Advanced Solid ...
Advanced Cancer
Malignant Solid...
Malignant Solid...
Malignant Neopl...
Malignant Tumor
TSC
TSC1
TSC2
Metastatic Soli...
Metastatic Neop...
nab-sirolimus
12 Years - Aadi Bioscience, Inc.
Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination TherapyNCT06391775
Malignant Solid...
GEN1055
Pembrolizumab
Standard Chemot...
18 Years - Genmab
A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and NivolumabNCT02518958
Malignant Solid...
Lymphoma
RRx-001
Nivolumab
18 Years - EpicentRx, Inc.
RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)NCT02801097
Malignant Solid...
Metastatic Canc...
Advanced Cancer
RRx-001
Irinotecan
18 Years - EpicentRx, Inc.
Safety Study of Increasing Doses of Combretastatin in Combination With Bevacizumab (Avastin) in Patients With Advanced Solid TumorsNCT00395434
Tumors
Combretastatin ...
Bevacizumab (Av...
18 Years - Mateon Therapeutics
Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data GenerationNCT02844400
Malignant Solid...
Hematologic Mal...
Biometric Devic...
Physical Perfor...
18 Years - UNC Lineberger Comprehensive Cancer Center
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor PatientsNCT05468359
Refractory Soli...
Hepatocellular ...
Malignant Solid...
Pediatric Cance...
Pediatric Solid...
Fibrolamellar C...
Atezolizumab
Sorafenib
Bevacizumab
Cyclophosphamid...
- 30 YearsSt. Jude Children's Research Hospital
Hydroxychloroquine + Vorinostat in Advanced Solid TumorsNCT01023737
Malignant Solid...
Hydroxychloroqu...
Vorinostat
16 Years - The University of Texas Health Science Center at San Antonio
Clinical Research on Comprehensive Treatment of Tuberculosis With Malignant Solid TumorNCT03551795
Malignant Solid...
Infusion of iNK...
18 Years - 65 YearsShanghai Public Health Clinical Center
Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid TumorsNCT05539157
Cutaneous Tumor
Malignant Solid...
JCXH-211
18 Years - 75 YearsImmorna Biotherapeutics, Inc.
A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients MalignanciesNCT03834662
Malignant Solid...
AVID200
18 Years - Formation Biologics
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid TumorsNCT01670175
Malignant Solid...
Childhood Solid...
Sirolimus, Cycl...
- 25 YearsUniversity of California, San Francisco
Safety and Pharmacokinetic Study of RRx-001 in Cancer SubjectsNCT01359982
Malignant Solid...
Lymphomas
RRx-001
RRx-001
RRx-001
RRx-001
RRx-001
RRx-001
18 Years - EpicentRx, Inc.
A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid TumorsNCT04571892
Malignant Solid...
Super circulati...
18 Years - 75 YearsShanghai East Hospital
An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With NivolumabNCT02754141
Malignant Solid...
BMS-986179
Nivolumab
rHuPH20
18 Years - Bristol-Myers Squibb
A Study of Ramucirumab (IMC-1121B) and Paclitaxel in Participants With Solid TumorsNCT01515306
Malignant Solid...
ramucirumab (IM...
paclitaxel
18 Years - Eli Lilly and Company
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: